Skip to main content
. Author manuscript; available in PMC: 2010 Apr 6.
Published in final edited form as: Exp Oncol. 2009 Jun;31(2):106–114.

Fig. 4.

Fig. 4

Patient with metastatic pancreatic carcinoma isolated to the liver. Pre-RFA contrast enhanced axial CT slice (a) shows detailed morphology with 4 possible targets (arrows) for treatment. PET (b) shows abnormal FDG uptake in 2 anterior liver lesions. Intermodality PET/CT fusion (c) localizes active lesions (crosshairs). Volume rendering (d) visualizes metabolic activity with 3 dimensional details